| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |